NFE2L2 and cancer: Studies using autophagy‐dependent cancer cell lines have demonstrated that they can adapt to autophagy inhibition through increasing mitochondrial‐derived vesicle production and inducing NRF2 signalling (Towers et al, 2019, 2021).